Mesa Laboratories, Inc. Set to Attend Upcoming Investor Conferences
Upcoming Conferences: Mesa Laboratories, Inc. executives Gary Owens and John Sakys will attend the Raymond James Napa Valley Small Cap Symposium on November 17, 2025, and the Jefferies London Healthcare Conference on November 20, 2025, featuring a fireside chat.
Webcast Availability: The Jefferies London Healthcare Conference fireside chat will be available via live webcast, with a replay accessible on Mesa Lab’s Investor Relations website.
Company Overview: Mesa Laboratories is a leader in designing and manufacturing life science tools and quality control solutions for the pharmaceutical, healthcare, and medical device industries.
Contact Information: For inquiries, Mesa Laboratories can be contacted through CEO Gary Owens or CFO John Sakys at their provided phone number and email address.
Trade with 70% Backtested Accuracy
Analyst Views on MLAB
About MLAB
About the author

Mesa Laboratories Declares $0.16 Quarterly Dividend Per Share
- Quarterly Dividend Announcement: Mesa Laboratories has declared a quarterly dividend of $0.16 per share of common stock, payable on March 16, 2026, which aims to reward shareholders and enhance investor confidence.
- Shareholder Record Date: The dividend will be distributed to shareholders of record at the close of business on February 28, 2026, ensuring eligible shareholders receive their returns promptly, thereby strengthening the company's relationship with investors.
- Company Background: Mesa is a global leader in the design and manufacture of life science tools and critical quality control solutions for the pharmaceutical, healthcare, and medical device industries, dedicated to improving product integrity and safety.
- Forward-Looking Statements: The company cautions investors about the risks and uncertainties associated with forward-looking statements, emphasizing that actual results may differ significantly from expectations, ensuring transparency and compliance.

Mesa Labs CEO to Present at J.P. Morgan Healthcare Conference on January 14, 2026
- Conference Participation: Mesa Laboratories' CEO Gary Owens and CFO John Sakys will present at the 44th Annual J.P. Morgan Healthcare Conference on January 14, 2026, showcasing the company's leadership in life science tools and critical quality control solutions.
- Live Webcast: The formal presentation is scheduled for 4:30 p.m. Pacific Time, and will be accessible via a live webcast, enhancing investor transparency and engagement with the company.
- Investor Relations: An archived replay of the webcast will be available on Mesa Labs' Investor Relations website after the presentation, ensuring that investors who cannot attend live can still access key information, thereby improving communication efficiency with stakeholders.
- Company Background: Mesa Laboratories is a global leader in the design and manufacture of life science tools and critical quality control solutions for regulated applications in the pharmaceutical, healthcare, and medical device industries, committed to enhancing product integrity and patient safety, further solidifying its market position.






